CAS 52705-93-8

Ginsenósido Rd

Descripción:

Ginsenósido Rd es un saponina triterpenoide que se encuentra principalmente en el ginseng, una planta conocida por sus propiedades medicinales. Es uno de los muchos ginsenósidos, que son los compuestos activos que se cree que contribuyen a los beneficios para la salud del ginseng. Ginsenósido Rd se caracteriza por su compleja estructura molecular, que incluye un esqueleto similar a un esteroide con múltiples grupos hidroxilo, lo que contribuye a su solubilidad y actividad biológica. Este compuesto es conocido por sus posibles efectos farmacológicos, incluyendo propiedades antiinflamatorias, neuroprotectoras y antioxidantes. Se ha estudiado por su capacidad para mejorar la función cognitiva y apoyar la salud cardiovascular. Ginsenósido Rd se extrae típicamente de las raíces de ginseng y se puede analizar utilizando diversas técnicas como la cromatografía líquida de alta resolución (HPLC). Su perfil de seguridad se considera generalmente favorable, aunque se necesita más investigación para comprender completamente sus mecanismos de acción y potencial terapéutico. Al igual que con cualquier compuesto bioactivo, los efectos pueden variar según la dosis, la formulación y las condiciones de salud individuales.

Fórmula: C₄₈H₈₂O₁₉

InChI: InChI=1/C48H82O18/c1-21(2)15-22(3)17-48(8,66-43-40(60)37(57)34(54)28(19-50)62-43)24-11-13-47(7)23-9-10-30-45(4,5)31(12-14-46(30,6)25(23)16-26(52)32(24)47)64-44-41(38(58)35(55)29(20-51)63-44)65-42-39(59)36(56)33(53)27(18-49)61-42/h15,22-44,49-60H,9-14,16-20H2,1-8H3/t22?,23?,24-,25?,26-,27+,28+,29+,30?,31?,32+,33+,34+,35+,36-,37-,38-,39+,40+,41+,42-,43-,44-,46+,47+,48-/m0/s1

Clave InChI: InChIKey=RLDVZILFNVRJTL-IWFVLDDISA-N

SMILES: C[C@]12[C@@]([C@]3(C)[C@@](CC1)(C(C)(C)[C@@H](O[C@H]4[C@H](O[C@@H]5O[C@H](CO)[C@@H](O)[C@H](O)[C@H]5O)[C@@H](O)[C@H](O)[C@@H](CO)O4)CC3)[H])(C[C@@H](O)[C@]6([C@@]2(C)CC[C@@]6([C@@](O[C@@H]7O[C@H](CO)[C@@H](O)[C@H](O)[C@H]7O)(CCC=C(C)C)C)[H])[H])[H]

Sinónimos:

• (3β,12β)-20-(β-<span class="text-smallcaps">D</smallcap>-Glucopyranosyloxy)-12-hydroxydammar-24-en-3-yl 2-O-β-<smallcap>D</smallcap>-glucopyranosyl-β-<smallcap>D</span>-glucopyranoside
• (8xi,9xi,12alpha,13alpha,14beta,17beta)-17-[(1S)-1-(beta-D-glucopyranosyloxy)-1,3,5-trimethylhex-4-en-1-yl]-12-hydroxy-4,4,10,14-tetramethylgonan-3-yl 2-O-beta-D-glucopyranosyl-beta-D-glucopyranoside
• 2-O-beta-D-Glucopyranosyl-(3beta,12beta)-20-(beta-D-glucopyranosyloxy)-12-hydroxydammara-24-en-3-yl-beta-D-glucopyranoside
• 3-O-β-<span class="text-smallcaps">D</smallcap>-Glucopyranosyl-(1→2)-β-<smallcap>D</smallcap>-glucopyranosyl-20-O-β-<smallcap>D</span>-glucopyranosyldammar-24-ene-3β,12β,20S-triol
• Chikusetsusaponin FK₇
• Dammarane, β-<span class="text-smallcaps">D</span>-glucopyranoside deriv.
• Ginsenoside Rd1
• Gold Theragran P.E.
• Gypenoside VIII
• beta-D-Glucopyranoside, (3-beta,12-beta)-20-(beta-D-glucopyranosyloxy)-12-hydroxydammar-24-en-3-yl 2-O-beta-D-glucopyranosyl-
• β-<span class="text-smallcaps">D</smallcap>-Glucopyranoside, (3β,12β)-20-(β-<smallcap>D</smallcap>-glucopyranosyloxy)-12-hydroxydammar-24-en-3-yl 2-O-β-<smallcap>D</span>-glucopyranosyl-
• Dammarane, β-D-glucopyranoside deriv.
• (3β,12β)-20-(β-D-Glucopyranosyloxy)-12-hydroxydammar-24-en-3-yl 2-O-β-D-glucopyranosyl-β-D-glucopyranoside
• Ginsenoside Rd
• β-D-Glucopyranoside, (3β,12β)-20-(β-D-glucopyranosyloxy)-12-hydroxydammar-24-en-3-yl 2-O-β-D-glucopyranosyl-
• GINSENOSIDE Rd hplc
• beta-d-glucopyranoside,(3-beta,12-beta)-20-(beta-d-glucopyranosyloxy)-12-hydro
• xydammar-24-en-3-yl2-o-beta-d-glucopyranosyl-
• 3β-[2-O-(β-D-Glucopyranosyl)-β-D-glucopyranosyloxy]-20-(β-D-glucopyranosyloxy)dammar-24-ene-12β-ol
• (20S)-3β-[2-O-(β-D-Glucopyranosyl)-β-D-glucopyranosyloxy]-20-(β-D-glucopyranosyloxy)dammar-24-ene-12β-ol
• β-D-Glucopyranoside,(3β,12β)-20-(β-D-
• Ginsenoside Rd std.
• GINSENOSIDE RD WITH HPLC
• (20S)-3β-[[2-O-(β-D-Glucopyranosyl)-β-D-glucopyranosyl]oxy]-20-(β-D-glucopyranosyloxy)dammaran-24-ene-12β-ol
• 20-(β-D-Glucopyranosyloxy)-12β-hydroxy-5α-dammar-24-ene-3β-yl 2-O-β-D-glucopyranosyl-β-D-glucopyranoside
• GINSENOOSIDERD
• [20-(β-D-Glucopyranosyloxy)-12β-hydroxydammar-24-en-3β-yl]2-O-β-D-glucopyranosyl-β-D-glucopyranoside
• Ginsenoside Rd (CAS# 52705-93-87)

Ginsenoside Rd

CAS: 52705-93-8

Ginsenoside Rd

Fórmula: C₄₈H₈₂O₁₈

Pureza: ≥98%

Peso molecular: 947.15

Ref: 54-BUP07726

Ginsenoside Rd

CAS: 52705-93-8

Fórmula: C₄₈H₈₂O₁₈

Forma y color: White To Off-White Solid

Peso molecular: 947.17

Ref: 4Z-G-157013

Ginsenoside Rd

CAS: 52705-93-8

Fórmula: C₄₈H₈₂O₁₈

Pureza: ≥ 98.0%

Forma y color: White to pale yellow powder

Peso molecular: 947.15

Ref: 7W-GC2429

Ginsenoside Rd

CAS: 52705-93-8

Ginsenoside Rd analytical standard provided with w/w absolute assay, to be used for quantitative titration.

Fórmula: C₄₈H₈₂O₁₈

Pureza: (HPLC) ≥98%

Forma y color: Powder

Peso molecular: 947.18

Ref: 11-0102S

Ginsenoside Rd

CAS: 52705-93-8

Ginsenoside Rd (Rd), a saponin isolated from the roots of panax notoginseng, Rd has immunological adjuvant activity, and elicits a Th1 and Th2 immune response by regulating production and gene expression of Th1 cytokines and Th2 cytokines.

Fórmula: C₄₈H₈₂O₁₈

Pureza: 95%~99%

Forma y color: White powder

Peso molecular: 947.166

Ref: BP-BP0661

Ginsenoside Rd (Standard)

CAS: 52705-93-8

Ginsenoside Rd (Standard) is a reference standard for research and analysis in studies involving Ginsenoside Rd. Ginsenoside Rd (Gypenoside VIII) may have properties that inhibit or prevent the growth of tumors.

Fórmula: C₄₈H₈₂O₁₈

Peso molecular: 947.1539

Ref: TM-TMSM-2692

Ginsenoside Rd

Producto controlado

CAS: 52705-93-8

Stability Hygroscopic
Applications Ginsenoside RD has been shown to attenuate tau protein phosphorylation via the PI3K/AKT/GSK-3β pathway after forebrain ischemia. This could be used to counter the risk of developing post-stroke dementia.
References Zhang, X. et al.: Neurochem. Res., 39, 1363 (2014); Zhu, D. et al.: J. Neurosci. Res., 92, 1217 (2014);

Fórmula: C₄₈H₈₂O₁₈

Forma y color: Neat

Peso molecular: 947.15

Ref: TR-G387620

Ginsenoside Rd

CAS: 52705-93-8

(2S,3R,4S,5S,6R)-2-(((2R,3R,4S,5S,6R)-4,5-Dihydroxy-2-(((3S,5R,8R,9R,10R,12R,13R,14R,17S)-12-hydroxy-4,4,8,10,14-pentamethyl-17-((S)-6-methyl-2-(((2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-yl)oxy)hept-5-en-2-yl)hexadecahydro-1H-cyclopenta[a]phenanthren-3-yl)oxy)-6-(hydroxymethyl)tetrahydro-2H-pyran-3-yl)oxy)-6-(hydroxymethyl)tetrahydro-2H-pyran-3,4,5-triol

Fórmula: C₄₈H₈₂O₁₈

Pureza: 98%

Peso molecular: 947.15

Ref: IN-DG9356

Ginsenoside Rd

CAS: 52705-93-8

Ginsenoside Rd (Gypenoside VIII) may have properties that inhibit or prevent the growth of tumors.

Fórmula: C₄₈H₈₂O₁₈

Pureza: 99.13% - 99.92%

Forma y color: White Solid

Peso molecular: 947.1539

Ref: TM-T2878

Ginsenoside Rd

CAS: 52705-93-8

Natural glycoside

Fórmula: C₄₈H₈₂O₁₈

Pureza: ≥ 90.0 % (HPLC)

Forma y color: Powder

Peso molecular: 947.17

Ref: 5G-89211

Ginsenoside Rd

CAS: 52705-93-8

Ginsenoside Rd is a bioactive compound, classified as a saponin, which is derived from the roots of Panax ginseng. This ginsenoside is a dammarane-type triterpenoid saponin and is one of the major active components found in ginseng extracts. The mode of action of Ginsenoside Rd involves multiple biochemical pathways, including anti-inflammatory, antioxidant, and neuroprotective effects. It modulates signaling pathways such as MAPK and PI3K/Akt, resulting in diverse biological activities.

Fórmula: C₄₈H₈₂O₁₈

Pureza: Min. 95%

Forma y color: White Powder

Peso molecular: 947.18 g/mol

Ref: 3D-OG09282

Ginsenoside Rd

CAS: 52705-93-8

Fórmula: C₄₈H₈₂O₁₈

Peso molecular: 947.2

Ref: BE-RMT16300

Ginsenoside Rd

CAS: 52705-93-8

Fórmula: C₄₈H₈₂O₁₈

Peso molecular: 947.2

Ref: BE-RMCG062013

Ginsenoside Rd

CAS: 52705-93-8

Fórmula: C₄₈H₈₂O₁₈

Pureza: >98.0%(HPLC)

Forma y color: White to Almost white powder to crystal

Peso molecular: 947.17

Ref: 3B-G0550

Ginsenoside Rd

CAS: 52705-93-8

Fórmula: C₄₈H₈₂O₁₈

Peso molecular: 947.2

Ref: ST-EA-CP-G62004